Perfromance Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Perfromance Wealth Partners's LLY Position: Q2 2026 in Review
Perfromance Wealth Partners increased its Eli Lilly (LLY) stake by 3.4% in Q2 2026, buying an estimated $154K and bringing the position to 4,570 shares worth $5.48M. The position accounts for 0.14% of the portfolio, ranked #37.
Perfromance Wealth Partners first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $62.2M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Perfromance Wealth Partners held 4,570 shares of Eli Lilly worth $5.48M as of Q2 2026.
- Perfromance Wealth Partners bought 151 Eli Lilly shares in Q2 2026, an estimated $154K.
- Eli Lilly made up 0.14% of Perfromance Wealth Partners's portfolio in Q2 2026, its #37 holding.
- Perfromance Wealth Partners first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
- Perfromance Wealth Partners's Eli Lilly position peaked at $62.2M in Q3 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Perfromance Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.